treatment of HIV
Drug-resistant forms of HIV can be spread between individuals who have not received anti-retroviral treatment, according to Professor Deenan Pillay from University College, London and the Health Protection Agency, speaking at the Society for General Microbiology meeting at Harrogate today, (Monday 30 March).
Researchers at the Tulane University School of Medicine, New Orleans, Louisiana have discovered that the HIV-1 protease inhibitors (PIs), such as nelfinavir included in highly active antiretroviral therapy (HAART) regimen for the treatment of HIV-1 patients, induce deleterious effects on insulin secretion mediated through the oxidative stress pathway.
Patients taking highly active antiretroviral therapy for the treatment of HIV/AIDS often lose fatty tissues in the face as a result of treatment, making them appear gaunt and emaciated. Silicone facial implants can help these patients achieve a healthier appearance and fuller face. As patients with HIV live longer, they are beginning to seek surgical procedures to help improve their appearance caused by the disease and treatment, the article states. Traditionally, facial wasting syndrome has been treated using the patient's own fat, but frequent adjustments and additional procedures were often required. Custom designed implants tend to remain stable in their position after implantation and retain their original size and structure.